Continuity of routine immunization programs in Canada during the COVID-19 pandemic

Introduction

The coronavirus disease 2019 (COVID-19) pandemic has disrupted societies worldwide, resulting in temporary business closures, the cancelling of events, and, central to this study, the interruption of routine immunization programs. In Canada, each province or territory (P/T) is responsible for administering health services, including routine immunizations. The processes for routine vaccine delivery in the P/Ts vary, although most primarily use public health and/or physician delivery (see Appendix 1 for further detail). Due to the pandemic, some public health clinics and physicians’ offices have restricted availability of in-person services, instead offering telephone or online appointments. Furthermore, the pandemic has placed additional strain on the Canadian health care system via COVID-19 testing and contact tracing, as well as health care utilization by COVID-19 patients.¹ The implementation of public health restrictions has also meant that many Canadians have either been unable or unwilling to attend immunization appointments.^2,3 As such, despite the recommendation made by the National Advisory Committee on Immunization (NACI) to continue routine immunizations to prevent vaccine-preventable disease outbreaks,³ it is likely that Canadian routine immunization programs have been adversely affected by disruptions from the COVID-19 pandemic.

Although Canadian data are not yet available, preliminary data from other jurisdictions have quantified the impact of these disruptions on routine immunization coverage levels since the start of the pandemic. In a global survey, 85% of respondents from 61 countries reported a decline in routine immunization rates in May compared to January and February 2020.⁴ McDonald et al.⁵ found that measles-mumps-rubella (MMR) immunization rates fell 19.8% in England in the three weeks following the introduction of physical distancing measures in late March 2020. Notably, data from New York City showed a 62% decrease in immunization for infants aged <2 years during the early stages of the pandemic (March-April) compared to the same time period in 2019.⁶ It is important to understand and document the processes that led to these drops in immunization coverage, and the strategies that have been undertaken to prevent or recover from them. Identifying the range of strategies, highlighting new and innovative approaches, and learning from successful and unsuccessful approaches will enhance our capacity to respond to similar challenges that we will undoubtedly face in the future.

Little is known about the impact of the COVID-19 pandemic on routine immunization programs in Canadian P/Ts and what measures have been taken by P/T public health officials to meet the challenges posed by the pandemic. As such, the current study was undertaken to capture and synthesize information about the continuity of routine immunization programs during the pandemic through interviews with public health representatives across Canada. We were particularly interested in ascertaining changes to routine immunization programs in response to the pandemic and plans to catch-up any missed immunizations.

Methods

This pan-Canadian environmental scan involved key informant structured interviews with public health leaders from P/Ts across Canada. The goal was to recruit public health leaders who were knowledgeable of immunization services in all 13 P/Ts. Canadian Immunization Committee members in each P/T were initially targeted for recruitment, but as some individuals were unavailable convenience sampling through referrals from members of the research team, which consists of individuals that partake in immunization research in Canada, P/T Ministries of Health, and the NACI Secretariat at the Public Health Agency of Canada was also used. Key informants were contacted via an initial email sent by the NACI Secretariat, inviting them to participate in the study. Interested individuals were emailed an information sheet and consent form. Informed consent was obtained after the nature of the study and any potential benefits and risks had been fully explained. Up to two email reminders were sent to non-responders to optimize response rate. Some participants were recruited via snowball sampling, with study participants suggesting additional key informants. Interviews (35-60 minutes long) were conducted by members of the research team (HS, AA, MK) from August through October 2020 via teleconference.

The focus of the interviews was to gain in-depth perspectives from individuals who had knowledge about or direct experience with delivery of routine immunization programs during the pandemic. Topics to be explored were identified from scientific literature and news articles, and augmented by the immunization experts on the research team, including the NACI Secretariat. This information was synthesized into questions about: how routine immunization delivery was affected during and after initial lockdown periods, what plans there were to catch-up missed doses, and major challenges and achievements in continuing routine immunization programs. The interview guide was reviewed and edited by immunization experts and pilot tested with an individual who worked in provincial immunization programming, but was not involved in the study, to check face and content validity, flow, and comprehension. Ethical approval for this study was obtained from the Health Research Ethics Board at the University of Alberta.

Interviews were audio-recorded and transcribed verbatim by one member of the research team (HS). The same team member then coded and categorized participant responses. Coding and categorization were validated by other team members (SM, AA) to ensure they accurately reflected and were fully representative of participants’ responses. Descriptive analysis of response counts was performed using Microsoft Excel.

Results

Invitation emails from the NACI Secretariat were sent to 35 potential participants: 13 agreed to participate, 1 declined, and 21 did not respond. Five more participants were recruited via referrals from other participants. Before the interview, participants were given the opportunity to invite other colleagues to provide additional perspectives on routine immunization programs. Therefore, some interviews contained more than one participant. In total, there were 18 interviews with 25 participants from 11 of the 13 P/Ts. Twelve participants provided a P/T-level perspective, 9 provided a regional/municipal perspective, and 4 provided both P/T and regional/municipal perspectives. Job titles of participants included positions such as Immunization Program or Policy Manager (n=7), Medical Officer of Health (n=5), and Public Health or Medical Consultant (n=3). Table 1 shows the full demographics of the study sample.

Interview results were synthesized into the following topics, presented below: changes in routine vaccine delivery due to the pandemic; plans for catch-up; and challenges and achievements related to routine immunization program continuity during the pandemic.

Changes in routine vaccine delivery due to the pandemic

Early pandemic period

During the early stages of the pandemic (i.e., March-April 2020, when lockdown measures were first introduced), all P/Ts reported changes to routine immunization programs, with programs being affected to varying degrees. School immunization programs were reported to be the most negatively affected (n=9), followed by preschool (n=2) and adult (n=2) programs. Infant, preschool, and maternal/prenatal programs were most often prioritized. Most P/Ts reported continuing their infant (n=11) and preschool programs (n=10) with adaptations, such as shortened appointment times (i.e., only providing immunizations) and implementation of COVID-19 public health restrictions (e.g. personal protective equipment [PPE], COVID-19 screening)). Almost half of P/Ts reported a reduction in available appointments for both of these programs (n=5). A few P/Ts reported temporary suspension of infant (n=3) and preschool (n=4) programs, particularly in regions with high COV D-19 incidence. Maternal/prenatal programs were also prioritized, with ten P/Ts commenting that these programs continued with adaptations for public health restrictions, but six also indicating a reduction in appointments. All P/Ts reported suspension of school-based vaccines, due to school closures in mid-March 2020. A few P/Ts reported suspension of adult (n=2) and older adult (n=3) programs, but overall these programs continued across P/Ts, often with reduced availability and prioritization for high-risk groups. Figure 1a shows all P/T responses for the early pandemic period.

• Download figure
• Open in new tab

Figure 1.

Routine immunization program changes (1a) during initial lockdown period (∼March-April 2020) (left) and (1b) after initial lockdown period (∼May-Oct) (right) (N=11).^a,b

Notes. ^aSee appendix A for list of routine programs in each P/T

^bSome P/T responses fall into more than one category, so totals may add up to more than 11.

^cSome P/Ts temporarily suspended the program in some but not all regions.

^dSome P/Ts continued immunizing high-risk groups only, although programs for the general population were suspended.

^eIn some P/Ts, only non-publicly funded vaccines (e.g., travel vaccines, shingles vaccine) were suspended.

^fSome P/Ts have resumed vaccination in some but not all regions.

Mid-pandemic period

In the period after the initial lockdown (i.e., May-October 2020), most P/Ts reported that infant (n=11), preschool (n=11), and maternal/prenatal (n=10) programs were continuing with adaptations, such as shorter appointment times or implementation of public health restrictions (e.g., PPE, COVID-19 screening). Some P/Ts reported continued suspension of school, adult, and older adult programs, but most P/Ts were continuing these programs with the same adaptations (Figure 1b).

Discussion

Public health and immunization experts have emphasized the critical need for the continuation of routine immunizations during the COVID-19 pandemic.^2,7,8 The maintenance of high immunization coverage rates in the population is essential to prevent vaccine-preventable disease outbreaks in the post-pandemic period. For example, multiple measles outbreaks occurred in Guinea in 2015 due to immunization disruptions during the Ebola epidemic.⁹ With COVID-19 lockdown periods causing disruptions to routine immunization, some experts predict that the incidence of diseases such as measles, pertussis, and polio may increase.¹⁰ It is estimated that at least 80 million children under one year of age are at risk of these diseases due to COVID-19-related disruptions in routine immunization.¹¹ Furthermore, missed immunization doses can be problematic as there is evidence that individuals who miss doses may be less likely to catch-up later.² Delaying catch-up of missed doses to the post-pandemic period may place additional strain on a health care system that is already overburdened from the COVID-19 pandemic.^2,12

Most public health representatives in our study were adamant about the importance of continuing immunization programs, while also following national and provincial guidelines to prevent COVID-19 transmission. Although there were some suspensions of routine immunization programs during the initial lockdown period, most P/Ts eventually resumed all programs with adaptations for COVID-19 restrictions. The suspension of routine immunization programs appears to be in line with global trends.¹³ Of 129 countries for which data were available, 53% reported moderate to severe disruptions or full suspension of immunization between March and April 2020.¹¹ In the current study, most P/Ts had catch-up via increasing clinics or providers and contacting clients to rebook appointments for infant, preschool, and school programs. While active catch-up efforts were not implemented for adult and older adult programs in most P/Ts, efforts to immunize these groups at other medical appointments were mentioned. P/Ts appeared to be aligning with Canada’s NACI recommendations for continuity of routine immunizations, with most or all prioritizing immunization for those under two years of age and pregnant women, taking precautions to prevent COVID-19 transmission, and combining vaccinations with other medical visits.²

The success in continuing most routine immunization offerings during the pandemic will not be achieved without considerable effort, with P/Ts reporting various challenges, most notably having limited resources due to pandemic response efforts, such as staff shortages, PPE shortages, and limited infrastructure to comply with public health restrictions. Resource shortages have been identified as a major challenge in other countries, with Chandir et al.¹⁴ reporting a shortage in PPE during the early weeks of the pandemic in Pakistan, and a reduction in the number of available vaccinators due to travel restrictions. Similarly, Ghatak et al.¹⁰ highlight lack of infrastructure to maintain social distancing and PPE shortages as contributing factors to the reduction in immunization services in India. Given that resource shortages were a challenge for all P/Ts, it may be important to consider factors such as accessing larger spaces for immunization to allow physical distancing and managing immunization programs with fewer staff in any future pandemic preparedness planning. P/Ts also mentioned that public health restrictions made it difficult to deliver routine immunization programs as normal, and that even if programs continued, public hesitancy to attend clinics meant that there was a reduction in attendance. This reduction in attendance aligns with other jurisdictions, with a survey of 400 pediatricians in Italy finding that 31.7% reported a reduction in parents’ compliance with mandatory vaccinations.¹²

Surveys of parents in other jurisdictions have found several barriers to vaccination during the pandemic, including uncertainty around whether vaccination services were operating,¹⁵ difficulties in making appointments,¹⁵ and fears of exposure to COVID-19.^15,16 In particular, public hesitancy to attend immunization clinics has been widely noted as a barrier to providing routine immunizations during the pandemic.^10,12,13,16 P/Ts in our study also reported that some clients were hesitant to attend immunization appointments, especially during early stages of the pandemic. These findings highlight the importance of clear, consistent, and timely communication from public health or immunization providers regarding the importance of routine immunization and the implementation of measures to prevent disease transmission in clinic settings. A recent study found that advice for parents to continue immunizations resulted in confusion and immunization delays due to conflict with stay-at-home orders.¹⁶ As well, offering additional hours or days specifically for immunization could encourage individuals to make in-person visits. P/Ts in our study mentioned offering immunizations at other medical appointments, which may be useful for catching up missed adult and older adult immunizations. As noted by MacDonald et al.,¹⁷ a multi-pronged approach will likely be needed to catch-up missed immunization doses, given the variation in COVID-19 incidence and public health restrictions across P/Ts.

Conclusion

Our findings show that routine immunization programs across Canadian P/Ts faced some disruptions due to the COVID-19 pandemic, particularly the school, adult, and older adult programs. Catch-up has been implemented for most programs, but there are continued challenges with resource shortages and public health restrictions. Further research is needed to determine the quantitative impact of the pandemic on routine vaccine coverage levels in order to identify potential risks of future vaccine-preventable disease outbreaks.

Authors’ Statement

All authors attest that they meet the ICMJE criteria for authorship.

HS – Conceptualization, investigation, data curation, formal analysis, writing (original draft, and review and editing)

AA – Conceptualization, investigation, data curation, supervision, project administration, formal analysis, writing (review and editing)

MD - Conceptualization, methodology, writing (review and editing) ED - Conceptualization, methodology, writing (review and editing)

AG – Conceptualization, methodology, funding acquisition, writing (review and editing) SMeyer – Conceptualization, methodology, writing (review and editing)

JR - Conceptualization, methodology, writing (review and editing) MS – Conceptualization, methodology, writing (review and editing) MT - Conceptualization, methodology, writing (review and editing)

SMacDonald – Conceptualization, methodology, funding acquisition, supervision, formal analysis, writing (original draft, and review and editing)

Conflict of Interest

MS is supported via salary awards from the BC Children’s Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research. MS has been an investigator on projects funded by GlaxoSmithKline, Merck, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines. All funds have been paid to his institute, and he has not received any personal payments.

Funding

This work was supported by an operating grant from the Canadian Institutes of Health Research. The funding source had no role in the research or submission process.